October 18, 2013
Results from the AREDS2 study further established lutein and zeaxanthin as go-to nutrients for eye health. But findings for omega-3s weren't as favorable.
While many in the industry hailed the results, they also pointed to design flaws. Watch this INSIDER exclusive interview with AREDS2 researcher Paul S. Bernstein, professor of ophthalmology and visual sciences, Moran Eye Center, The University of Utah, to learn what he would have changed about the study design. He also gives his expectations for an AREDS3.
Editor's note: Looking for ingredients to support your next product launch in the Eye Health category? Leading suppliers, including Divis, DSM, Horphag, OmniActives and Valensa, will be at SupplySide West in Las Vegas, Nov. 12 to 16. Click here for the full exhibitor search , or register now .
You May Also Like
FDA’s Dr. Califf expresses skepticism of supplement health claimsOct 04, 2023
8 ingredients and product format trends driving the shift from sports to active nutritionOct 04, 2023
Nordic fails to get “natural” suit dismissedOct 04, 2023
High prices for lavender oil lead to report on adulteration risksOct 03, 2023